Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleLenvatinib in Kombination mit Everolimus als Zweitlinientherapie zugelassen.AuthorsKrampe-Scheidler, AnnePublicationOncology Research & Treatment, 2016, Vol 39, Issue 10, p665ISSN2296-5270Publication typeArticle